> Pfizer ($PFE) is investing $5.4 million in a Ferrosan packaging facility in Romania. Report
> Of the 63 Class I and II drugs the DEA regulates, 22 will be allowed production increases next year and 10 will see decreases. Report
> New Jersey compounder Pharmacy Creations is recalling four lots of products suspected of not being sterile. Release
> Almac, the contract development and manufacturing organization, along with Bangor University in Wales and Hockley International, have received a grant from the U.K. of £1 million to work on turing oil in biologic products through an enzymatic process. Release
And Finally... The FDA had U.S. Marshals seize unapproved drugs from Asbury Park, NJ-based Flawless Beauty including injectable products that were advertised for treating "degenerative brain and liver diseases." Release